Related Articles
Genetic alteration of p53, but not overexpression of intratumoral p53 protein, or serum p53 antibody is a prognostic factor in sporadic colorectal adenocarcinoma
EGFR mutation: Significance as a stratification factor in the era of molecular-targeted therapy
Molecular and immunological aspects of p53 and p53-autoantibodies in head and neck squamous cell carcinoma
Prognostic significance of p53 and Bcl-2 in acute lymphoblastic leukemia
Impact of genetic profiles on the efficacy of anti-EGFR antibodies in metastatic colorectal cancer with KRAS mutation